Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction

Background: The feasibility of spironolactone withdrawal in dilated cardiomyopathy patients with improved ejection fraction remains unknown. This study sought to determine whether spironolactone can be withdrawn safely in this circumstance.Methods: Consecutive patients with idiopathic dilated cardio...

Full description

Bibliographic Details
Main Authors: Yanjia Chen, Zeping Qiu, Jie Jiang, Xiuxiu Su, Fanyi Huang, Jing Tang, Wei Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
heart failure with improved ejection fraction
spironolactone
dilated cardiomyopathy
withdrawal
heart failure management
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.725399/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.725399/full

Similar Items